Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cross Country Healthcare (CCRN) Profit After Tax: 2009-2024

Historic Profit After Tax for Cross Country Healthcare (CCRN) over the last 16 years, with FY2024 value amounting to -$14.6 million.

  • Cross Country Healthcare's Profit After Tax fell 28684.93% to -$4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.7 million, marking a year-over-year decrease of 78815.86%. This contributed to the annual value of -$14.6 million for FY2024, which is 12004.1% down from last year.
  • As of FY2024, Cross Country Healthcare's Profit After Tax stood at -$14.6 million, which was down 12004.1% from $72.6 million recorded in FY2023.
  • Cross Country Healthcare's Profit After Tax's 5-year high stood at $186.0 million during FY2022, with a 5-year trough of -$14.6 million in FY2024.
  • Over the past 5 years, Cross Country Healthcare's median Profit After Tax value was $72.6 million (recorded in 2023), while the average stood at $72.6 million.
  • Its Profit After Tax has fluctuated over the past 5 years, first surged by 111837.68% in 2021, then tumbled by 12004.1% in 2024.
  • Over the past 5 years, Cross Country Healthcare's Profit After Tax (Annual) stood at -$13.0 million in 2020, then surged by 1118.38% to $132.0 million in 2021, then soared by 40.89% to $186.0 million in 2022, then crashed by 60.95% to $72.6 million in 2023, then tumbled by 120.04% to -$14.6 million in 2024.
  • Its last three reported values are -$14.6 million in FY2024, $72.6 million for FY2023, and $186.0 million during FY2022.